KalGene gears up to manufacture and test promising Alzheimer’s treatment with NRC, McGill and CIMTEC

KalGene Pharmaceuticals and the National Research Council of Canada (NRC) are proud to announce the signature of an agreement worth over $1M to develop, scale up, and transfer the technology needed...

• Read more about KalGene gears up to manufacture and test promising Alzheimer’s treatment with NRC, McGill and CIMTEC